Expression of human prostatic acid phosphatase activity and the growth of prostate carcinoma cells.

Human prostatic acid phosphatase (PAcP) is a tissue-specific differentiation antigen and is the major phosphotyrosyl (p-tyr) protein phosphatase in normal differentiated prostate epithelial cells. In prostate carcinomas, cellular PAcP has a low expression. We examined the expression of cellular PAcP activity and its correlation with cell growth that may lead us to understand the role of tyrosine phosphorylation in human prostate cells. LNCaP cells, which expressed the highest cellular PAcP activity, had the slowest growth rate and the lowest p-tyr level among three human prostate carcinoma cell lines: LNCaP, DU145, and PC-3. This inverse correlation was further examined in LNCaP cells, since these cells remain hormone-sensitive. Androgen, a classical stimulator of prostate cells, stimulated the growth of LNCaP cells while cellular PAcP activity decreased and p-tyr levels increased. This phenomenon was also observed when cells were treated with epidermal growth factor and fetal bovine serum. Both epidermal growth factor and fetal bovine serum stimulated the growth of LNCaP cells whereas cellular PAcP activity decreased. Furthermore, when cell growth was arrested at low temperatures (23 degrees C), cellular PAcP activity was elevated. To establish the relationship of cellular PAcP activity with cell growth rate, we transfected a complementary DNA encoding the full length PAcP protein into another human prostate carcinoma line, PC-3, that lacks endogenous PAcP. Two stable transfectants, designated PC-18 and PC-416 cells, were obtained and shown to express PAcP mRNA transcribed from the transfected complementary DNA. The expression of PAcP activity in PC-416 cells, but not PC-18 cells, was associated with a lower p-tyr level and a slower growth rate than control cells transfected with the expression vector alone. In conclusion, in LNCaP cells, the stimulated cell growth is associated with an increased p-tyr level and a decreased cellular PAcP activity. In PAcP complementary DNA-transfected PC-416 cells, the low level of p-tyr corresponds to a slow growth rate.

[1]  P. Nowell,et al.  Receptor protein-tyrosine phosphatase gamma is a candidate tumor suppressor gene at human chromosome region 3p21. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[2]  B. Vogelstein,et al.  Suppression of human colorectal carcinoma cell growth by wild-type p53. , 1990, Science.

[3]  P. Vihko,et al.  Gene expression and prostate specificity of human prostatic acid phosphatase (PAP): evaluation by RNA blot analyses. , 1990, Biochimica et biophysica acta.

[4]  P. Johnson,et al.  Expression of CD45 alters phosphorylation of the lck-encoded tyrosine protein kinase in murine lymphoma T-cell lines. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Beach,et al.  Reversible tyrosine phosphorylation of cdc2: Dephosphorylation accompanies activation during entry into mitosis , 1989, Cell.

[6]  E. Krebs,et al.  Human placenta protein-tyrosine-phosphatase: amino acid sequence and relationship to a family of receptor-like proteins. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[7]  E. Krebs,et al.  cDNA isolated from a human T-cell library encodes a member of the protein-tyrosine-phosphatase family. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[8]  L. Deaven,et al.  Human prostatic acid phosphatase: cDNA cloning, gene mapping and protein sequence homology with lysosomal acid phosphatase. , 1989, Biochemical and biophysical research communications.

[9]  E. Palen.  [Phosphoprotein phosphatases]. , 1989, Postepy biochemii.

[10]  K. Lau,et al.  Phosphotyrosyl protein phosphatases. , 1989, The Biochemical journal.

[11]  G. Clinton,et al.  The epidermal growth factor receptor from prostate cells is dephosphorylated by a prostate-specific phosphotyrosyl phosphatase. , 1988, Molecular and cellular biology.

[12]  N. Tonks,et al.  The leukocyte common antigen (CD45): a putative receptor-linked protein tyrosine phosphatase. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[13]  P. Vihko,et al.  Molecular cloning and sequence analysis of cDNA encoding human prostatic acid phosphatase , 1988, FEBS letters.

[14]  A. Sartorelli,et al.  Biochemical characterization of tyrosine kinase and phosphotyrosine phosphatase activities of HL-60 leukemia cells. , 1988, Cancer research.

[15]  A. Schuurmans,et al.  Androgens stimulate both growth rate and epidermal growth factor receptor activity of the human prostate tumor cell LNCaP , 1988, The Prostate.

[16]  A. Ullrich,et al.  Growth factor receptor tyrosine kinases. , 1988, Annual review of biochemistry.

[17]  A. Sartorelli,et al.  Alterations in tyrosine phosphorylation during the granulocytic maturation of HL-60 leukemia cells. , 1988, Cancer research.

[18]  J. Brugge,et al.  Detection of phosphotyrosine-containing proteins in polyomavirus middle tumor antigen-transformed cells after treatment with a phosphotyrosine phosphatase inhibitor , 1987, Molecular and cellular biology.

[19]  C. Li,et al.  Alteration of acid phosphatase isoenzyme in a human prostatic cancer cell line. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[20]  G. Clinton,et al.  Human prostatic acid phosphatase has phosphotyrosyl protein phosphatase activity. , 1986, The Biochemical journal.

[21]  E. Fischer,et al.  8 Phosphoprotein Phosphatases , 1986 .

[22]  B. Sefton.  The viral tyrosine protein kinases. , 1986, Current topics in microbiology and immunology.

[23]  J. Klarlund.  Transformation of cells by an inhibitor of phosphatases acting on phosphotyrosine in proteins , 1985, Cell.

[24]  D. Learn,et al.  Distribution of prostatic acid phosphatase isoenzymes in normal and cancerous states. , 1984, Clinica chimica acta; international journal of clinical chemistry.

[25]  S. Tamura,et al.  A novel mechanism for the insulin-like effect of vanadate on glycogen synthase in rat adipocytes. , 1984, The Journal of biological chemistry.

[26]  C. Heldin,et al.  Growth factors: Mechanism of action and relation to oncogenes , 1984, Cell.

[27]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[28]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[29]  G. Murphy,et al.  LNCaP model of human prostatic carcinoma. , 1983, Cancer research.

[30]  J. Foulkes,et al.  Phosphotyrosyl-protein phosphatases. , 1983, Current topics in microbiology and immunology.

[31]  Richard S. Smith,et al.  COMPARISON OF PROSTATIC AND NONPROSTATIC ACID PHOSPHATASE * , 1982, Annals of the New York Academy of Sciences.

[32]  T. M. Chu,et al.  Expression of prostatic acid phosphatase in human prostate cancer. , 1981, Cancer letters.

[33]  Jonathan A. Cooper,et al.  Epidermal growth factor induces rapid tyrosine phosphorylation of proteins in A431 human tumor cells , 1981, Cell.

[34]  J. Lechner,et al.  Establishment and characterization of a human prostatic carcinoma cell line (PC-3). , 1979, Investigative urology.

[35]  R. Wicks,et al.  Basic Statistics for Health Science Students , 1979, The Mathematical Gazette.

[36]  P. Vihko.  Human prostatic acid phosphatases: purification of a minor enzyme and comparisons of the enzymes. , 1979, Investigative urology.

[37]  D. Paulson,et al.  Isolation of a human prostate carcinoma cell line (DU 145) , 1978, International journal of cancer.

[38]  A. Foti,et al.  Isozymes of acid phosphatase in normal and cancerous human prostatic tissue. , 1977, Cancer research.

[39]  L. Yam.  Clinical significance of the human acid phosphatases: a review. , 1974, The American journal of medicine.

[40]  F. Gyoerkey.  Some aspects of cancer of the prostate gland , 1973 .

[41]  C. Huggins,et al.  Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate , 1941, CA: a cancer journal for clinicians.

[42]  For April. , 1903 .